Skip to main content
OpenTrials
Completed

NCT Number: NCT05778968

Etco2 Levels on the End-tidal Concentration of Sevoflurane

he assessment of adequate levels of anaesthesia traditionally relies not only on a patient's movement but also on the hemodynamic response (or both) to a surgical stimulus

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

tarek Abdelhay Mostafa

Tanta, El Gharbyia, 31111, Egypt

About this study

Currently a derivative of MAC namely, end tidal partial pressure (FET) displayed on the work station as concentration , maybe an alternative useful measure of the anaesthetic effect of an inhaled anaesthetic agent

. Many pharmacological factors have been associated with alterations in MAC and Mac derivatives such as nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and anesthetics.

However, few studies have focused on physiological factors, such as hypercarbia or hypocarbia. A correlation has been found between Paco2 and Etco2 in ventilated patients with healthy lungs. Some authors have suggested that Etco2 could be considered appropriate for estimating Paco2 even in critical patients. Knowledge of the effects of Paco2 on end tidal concentration of sevoflurane among patients undergoing laparoscopic cholecystectomy may help anaesthesiologists titrate sevoflurane carefully and precisely during different mechanical ventilation settings to avoid dose-dependent hypotension, impaired cardiac contractility, and hypothermia caused by excessive anaesthetic depth of sevoflurane.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • American Society of anaesthesiologist ASA physical status I, II
  • admitted for laparoscopic cholecystectomy

Exclusion criteria

  • Refusal of patients.
  • Patients with renal or liver dysfunction.
  • Patients with chronic pain other than cholelithiasis.
  • Cardiac disorders as uncontrolled hypertension, arrhythmia, Ischaemic heart disease, valvular heart disease and pulmonary hypertension.
  • Patient with haematological disorder as Sickle cell disease.
  • Chest patient as asthma, COPD.
  • Combined surgery .
  • History of allergy to any of the study drugs.
  • Patients with communication problems, cognitive dysfunction, or psychological disorders.
  • Patients who received analgesics or sedatives 24 h before a scheduled surgery.
  • Alcohol or drug abuse.

Treatment and study plan

low etco2

Procedure

Etco2 levels will be adjusted at levels ranging between 25 mm Hg and 30 mm Hg

normal etco2

Procedure

Etco2 levels will be adjusted at levels ranging between 31 mm Hg and 40 mm Hg

high etco2

Procedure

Etco2 levels will be adjusted at levels ranging between 41 mm Hg and 45 mm Hg

Primary outcomes

  1. end tidal concentration of sevoflurane

    Time frame: Total time of operation

    end tidal concentration of sevoflurane is measured by multiple gas analyser during operation

Sponsors and collaborators

Lead sponsor

Tanta University

Other

Registry information

Official study title

The Effect of Different Etco2 Levels on the End-tidal Concentration of Sevoflurane in Patients Undergoing Laparoscopic Cholecystectomy

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Mar 22, 2023
Registry last updated
Jul 30, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.